Company Profile
Pulmatrix Stock Price, News & Analysis
- Ticker:
- PULM
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.66 USD (+0.61%)
Close
Last updated: August 6, 2026
4.82M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, PULM closed up 0.61% at $1.66. No new same-company headline was identified in the current news window.
Company overview
Business overview
Pulmatrix is a biotechnology company focused on inhaled therapies and pulmonary disease. Its platform seeks to deliver drugs directly to the lungs to improve local exposure and tolerability.
Geographic Base and Sector Classification
Pulmatrix is headquartered in the United States and listed on NASDAQ. It sits in specialty biotech with a respiratory focus.
Business Model Characteristics
The business depends on formulation success, clinical data, and the ability to create value from inhaled delivery technology. Investors usually watch proof-of-concept results and partnership options.
Position Within the Biotechnology Landscape
Pulmatrix occupies a delivery-platform niche within biotech. The stock is driven by whether inhaled formulation science can create differentiated respiratory therapies.
Future catalysts
For Pulmatrix, the near-term story still runs through its latest development priorities. Recent commentary puts the focus on the next company-specific pipeline update. That leaves the stock tied to whether the next milestone lands on schedule.
Recent news
- 01
Pulmatrix Announces First Quarter 2026 Financial Results
Source: Pulmatrix
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Pulmatrix (PULM)?
Pulmatrix (PULM) most recently closed at 1.66 USD, a +0.61% move versus the previous session.
What is the market cap of Pulmatrix (PULM)?
Pulmatrix currently has a market capitalization of 4.82M USD on BioPharmSignal.
What does Pulmatrix do?
Pulmatrix is a biotechnology company focused on inhaled therapies and pulmonary disease. Its platform seeks to deliver drugs directly to the lungs to improve local exposure and tolerability.
On which exchange is PULM stock listed?
Pulmatrix (PULM) is associated with NASDAQ, United States, Biopharma.
What is Pulmatrix?
For Pulmatrix, the near-term story still runs through its latest development priorities.
Which conditions is Pulmatrix targeting with Pulmatrix?
For Pulmatrix, the near-term story still runs through its latest development priorities.
How does Pulmatrix describe recent progress with Pulmatrix?
For Pulmatrix, the near-term story still runs through its latest development priorities.
What is Recent?
Recent commentary puts the focus on the next company-specific pipeline update.